Filing Details
- Accession Number:
- 0001140361-13-042285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-13 19:08:19
- Reporting Period:
- 2013-11-11
- Filing Date:
- 2013-11-13
- Accepted Time:
- 2013-11-13 19:08:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420859 | E Thomas Daley | C/O Raptor Pharmaceutical Corp. 5 Hamilton Landing, Suite 160 Novato CA 94949 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-11-11 | 15,000 | $12.79 | 54,906 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
- This transaction was executed in multiple trades at prices ranging from $12.33 to $13.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.